Gene · 501
Papers3,847
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
701 to 720 of 3,847
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Promising therapeutic aspects in human genetic imprinting disorders. | Clin Epigenetics | 2022 | 36371218 | PubTator, text mining | PubMed |
| Genome-Wide Transcriptional Profiling Reveals PHACTR1 as a Novel Molecular Target of Resveratrol in Endothelial Homeostasis. | Nutrients | 2022 | 36364780 | PubTator, text mining | PubMed |
| Erectile Dysfunction: Causes, Diagnosis and Treatment: An Update. | J Clin Med | 2022 | 36362656 | PubTator, text mining | PubMed |
| Early life exposure to unpredictable parental sensory signals shapes cognitive development across three species. | Front Behav Neurosci | 2022 | 36338881 | PubTator, text mining | PubMed |
| Comparative transcriptome and metabolome analysis reveal key regulatory defense networks and genes involved in enhanced salt tolerance of Actinidia (kiwifruit). | Hortic Res | 2022 | 36338850 | PubTator, text mining | PubMed |
| Deciphering the impact of genetic variation on human polyadenylation using APARENT2. | Genome Biol | 2022 | 36335397 | PubTator, text mining | PubMed |
| Metabolomic, Lipidomic, Transcriptomic, and Metagenomic Analyses in Mice Exposed to PFOS and Fed Soluble and Insoluble Dietary Fibers. | Environ Health Perspect | 2022 | 36331819 | PubTator, text mining | PubMed |
| Genomic Analysis of Halotolerant Bacterial Strains Martelella soudanensis NC18T and NC20. | J Microbiol Biotechnol | 2022 | 36330756 | PubTator, text mining | PubMed |
| The change of plasma metabolic profile and gut microbiome dysbiosis in patients with rheumatoid arthritis. | Front Microbiol | 2022 | 36329847 | PubTator, text mining | PubMed |
| Preparation and sustained-release properties of poly(lactic acid)/graphene oxide porous biomimetic composite scaffolds loaded with salvianolic acid B. | RSC Adv | 2022 | 36329763 | PubTator, text mining | PubMed |
| Case report: PLPHP deficiency, a rare but important cause of B6-responsive disorders: A report of three novel individuals and review of 51 cases. | Front Neurol | 2022 | 36324377 | PubTator, text mining | PubMed |
| Genetic Testing to Inform Epilepsy Treatment Management From an International Study of Clinical Practice. | JAMA Neurol | 2022 | 36315135 | PubTator, text mining | PubMed |
| Individually tailored home-based physiotherapy program makes sustainable improvement in exercise capacity and daily physical activity in patients with pulmonary arterial hypertension. | Ther Adv Respir Dis | 2022 | 36314474 | PubTator, text mining | PubMed |
| The cAMP-signaling cancers: Clinically-divergent disorders with a common central pathway. | Front Endocrinol (Lausanne) | 2022 | 36313756 | PubTator, text mining | PubMed |
| Implications of trimethylamine N-oxide (TMAO) and Betaine in Human Health: Beyond Being Osmoprotective Compounds. | Front Mol Biosci | 2022 | 36310589 | PubTator, text mining | PubMed |
| Pyridoxine-dependent Epilepsy caused by a Novel homozygous mutation in PLPBP Gene. | Metab Brain Dis | 2022 | 36308585 | PubTator, text mining | PubMed |
| Human ultrarare genetic disorders of sulfur metabolism demonstrate redundancies in H2S homeostasis. | Redox Biol | 2022 | 36306676 | PubTator, text mining | PubMed |
| The Tumor Invasion Paradox in Cancer Stem Cell-Driven Solid Tumors. | Bull Math Biol | 2022 | 36301402 | PubTator, text mining | PubMed |
| Current and investigational drugs in early clinical development for portal hypertension. | Front Med (Lausanne) | 2022 | 36300180 | PubTator, text mining | PubMed |
| Targeting aldehyde dehydrogenase for prostate cancer therapies. | Front Oncol | 2022 | 36300093 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/501/papers?page=36